Promega Corporation is a global life sciences company applying biochemistry and molecular biology to develop innovative products for research and applied technology. Its mission is to be a responsive worldwide supplier of biological reagents and reagent systems. The company serves researchers, clinical and diagnostic developers, forensic specialists, and other scientific users with products spanning cell biology, nucleic acid analysis, protein analysis, molecular diagnostics, human identification, and laboratory equipment and supplies.

Promega’s technologies include bioluminescence, NanoLuc® luciferase, HaloTag® protein labeling, HiBiT protein tagging, and NanoBRET® target engagement. Its offerings support research into infectious and metabolic diseases, neuroscience, inflammation, and drug discovery, as well as applications such as CRISPR tagging, live-cell assays, and forensic DNA analysis. Services include custom manufacturing, mRNA manufacturing, assay development, screening, clinical assay development, and companion diagnostic support. Promega also provides scientific resources, product documentation, technical and customer support, and specialized partnership services. With a broad portfolio connecting reagents, technologies, instruments, and services, the company helps customers pursue scientific research and applied life science work.